PhD, FHEA
Daniel is a commercialisation and intellectual property management professional with experience gained in a world leading technology transfer office (University of Manchester Innovation Factory) and in an industrial biotech startup (The Supplant Company – VC backed).
Expertise
Daniel led the intellectual property (IP) strategy for The Supplant Company resulting in the company hitting almost all IP milestones set at the series A funding round. During his time at the technology transfer office, Daniel worked on the commercialisation of technologies spanning a wide range of technical fields from a material science software, all the way to an oncology panel diagnostic technology.
Academic
Daniel has a strong academic background in chemistry, chemical engineering and material science with a BSc in chemical engineering and materials science from Polytechnic University of Bucharest (Head of class – maximum grade) and a PhD in inorganic chemistry from the University of Manchester (President’s Doctoral Scholar Award). Daniel is also a fellow of the Higher Education awarded for his teaching activity at the University of Manchester.
Recent Work
Daniel’s recent work includes the IP strategy management of the Supplant Company, but also valuation of different technologies from the University of Manchester.
Membership & Organisations
Daniel is a member of the Society of Chemical Industry (SCI).
Sectors
Sign up to our mailing list to receive Mathys Matters, our monthly newsletter covering the latest IP news, industry insights, events and case law.
If you are interested in receiving quarterly newsletters relevant to our core sector groups - IT & engineering ('Inside Wires') and life sciences & chemistry ('Under the Microscope') - please select your preference(s) below:
Please select your practice area(s) of interest:
Mathys & Squire uses cookies
We use cookies to ensure you get the best experience on our website. More details are available via our Cookie Policy.